406 related articles for article (PubMed ID: 3002610)
1. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
[TBL] [Abstract][Full Text] [Related]
3. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
4. Growth factor production by human colon carcinoma cell lines.
Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
[TBL] [Abstract][Full Text] [Related]
5. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
6. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
7. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells.
Sherwin SA; Minna JD; Gazdar AF; Todaro GJ
Cancer Res; 1981 Sep; 41(9 Pt 1):3538-42. PubMed ID: 6973391
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
12. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
13. Characterization of estrogen responsive transforming activity in human breast cancer cell lines.
Dickson RB; Bates SE; McManaway ME; Lippman ME
Cancer Res; 1986 Apr; 46(4 Pt 1):1707-13. PubMed ID: 2418952
[TBL] [Abstract][Full Text] [Related]
14. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
Carr BI; Hayashi I; Branum EL; Moses HL
Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
[TBL] [Abstract][Full Text] [Related]
16. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Korc M; Haussler CA; Trookman NS
Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
[TBL] [Abstract][Full Text] [Related]
20. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]